Treatment of lung cancer
197 results
1 - 100
Elemene for the treatment of lung cancer: Cochrane systematic review- Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non‐small cell lung cancer
- First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell lung cancer
- Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non‐small‐cell lung cancer and EGFR mutation
- Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) plus platinum‐etoposide versus platinum‐etoposide alone for first‐line treatment of extensive small cell lung cancer
- Interventions for smoking cessation in people diagnosed with lung cancer
- Drugs for preventing lung cancer in healthy people
- Chemotherapy versus best supportive care for extensive small cell lung cancer: Cochrane systematic review
- Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer: Cochrane systematic review
- Exercise training for advanced lung cancer
- Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer
- Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer
- Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review
- Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission: Cochrane systematic review
- Surgery for local and locally advanced non‐small cell lung cancer
- Screening for lung cancer
- Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): Cochrane systematic review
- Surgery for limited‐stage small‐cell lung cancer
- Chemotherapy for non‐small cell lung cancer
- Surgery versus radiosurgery for patients with a solitary brain metastasis from non‐small cell lung cancer
- Postoperative radiotherapy for non‐small cell lung cancer
- Chemotherapy for brain metastases from small cell lung cancer: Cochrane systematic review
- Adjuvant chemotherapy for resected early-stage non-small cell lung cancer: Cochrane systematic review
- Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
- Non‐invasive interventions for improving well‐being and quality of life in patients with lung cancer
- Second‐line chemotherapy for non‐small cell lung cancer
- Palliative radiotherapy regimens for patients with thoracic symptoms from non‐small cell lung cancer
- PET‐CT for assessing mediastinal lymph node involvement in patients with suspected resectable non‐small cell lung cancer
- Early versus late chest radiotherapy in patients with limited‐stage small cell lung cancer
- Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer
- Palliative endobronchial brachytherapy for non‐small cell lung cancer
- Best first‐line therapy for people with advanced non‐small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status
- Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer: Cochrane systematic review
- Surgical sealant for preventing air leaks after pulmonary resections in patients with lung cancer: Cochrane systematic review
- Prophylactic cranial irradiation for extensive‐stage small cell lung cancer
- Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation
- Interventions for cough in cancer
- Post-operative radiotherapy for ductal carcinoma in situ of the breast: Cochrane systematic review
- Immunotherapy (excluding checkpoint inhibitors) for stage I to III non‐small cell lung cancer treated with surgery or radiotherapy with curative intent
- Exercise training undertaken by people within 12 months of lung resection for non‐small cell lung cancer
- Chemotherapy and surgery versus surgery alone in non‐small cell lung cancer
- Chemotherapy for advanced non‐small cell lung cancer in the elderly population
- Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: Cochrane systematic review
- Stereotactic body radiation therapy versus more fractionated radical radiotherapy for adults with stage I/II non‐small cell lung cancer: a systematic review and network meta‐analysis
- Physical exercise training interventions for children and young adults during and after treatment for childhood cancer
- Parenteral anticoagulation in ambulatory patients with cancer
- Erythropoietin or Darbepoetin for patients with cancer ‐ meta‐analysis based on individual patient data
- Exercise for cancer cachexia in adults
- Systemic corticosteroids for the management of cancer‐related breathlessness (dyspnoea) in adults
- Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with unprovoked VTE
- Psychosocial interventions for reducing fatigue during cancer treatment in adults
- Concurrent chemoradiotherapy in non-small cell lung cancer: Cochrane systematic review
- PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer
- Pleurodesis for malignant pleural effusions: Cochrane systematic review
- Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases: Cochrane systematic review
- Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
- Short term benefits for laparoscopic colorectal resection
- Intermittent versus continuous androgen suppression for prostatic cancer